Knowledge Hub

Global Alopecia Drugs Market To Grow At A CAGR Of 5.02% During The Period 2016-2020

Press Release   •   Nov 24, 2016 04:57 EST

MarketResearchReports.biz has recently announced the addition of a market study “ Global Alopecia Drugs Market 2016-2020 ”, is a comparative analysis of the global market.

About Alopecia Drugs

Alopecia is a loss of hair and can occur at any age across the genders. The exact cause of this disorder is unknown, but many factors are assumed to be responsible for developing alopecia. Few of the primary ones are a sedentary lifestyle, unhealthy diets, and side effects of certain medical treatments. Moreover, hormonal imbalance and aging increase the probability of developing a chronic disease like cancer, arthritis, depression, and hypertension, which would also lead to hair loss, especially among middle-to-late-aged people.

Technavios analysts forecast the global alopecia drugs market to grow at a CAGR of 5.02% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global alopecia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of alopecia drugs.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Alopecia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

GlaxoSmithKline

Johnson & Johnson

Merck

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/877700

Other prominent vendors

Aclaris Therapeutics

Actelion Pharmaceuticals

Almirall

AndroScience

Anterios

Aqua Pharmaceuticals

Astellas Pharma

Bayer HealthCare

BERG Health

BiologicsMD

BioPharmX

Celtaxsys

Cipher Pharmaceuticals

Concert Pharmaceuticals

Cosmo Pharmaceuticals

Dermira

Elorac

F. Hoffmann-La Roche

Foamix

Guthy-Renker

Helix BioMedix

Hygeia Therapeutics

Hyundai Pharm

Incyte

Kasiak Research

Kythera Biopharmaceuticals

Mylan

NovaLead Pharma

Novan

Oculus Innovative Sciences

Paratek Pharmaceuticals

Photocure

Polichem

Promius Pharma

Ranbaxy Laboratories

Reckitt Benckiser

Regience

Samumed

RepliCel

Skinvisible Pharmaceuticals

Teva Pharmaceutical

Versapharm

XBiotech

Market driver

Popularity of off-label and OTC drugs

For a full, detailed list, view our report

Market challenge

Limited availability of approved drugs

For a full, detailed list, view our report

Market trend

Emergence of laser technology and platelet-rich plasma (PRP) therapy

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.